Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,718.25
(
0.28%
)
US TECH 100
24,148.40
(
0.55%
)
Dow Jones
47,054.25
(
0.23%
)
Brent Oil
100.21
(
1.94%
)
Bitcoin
73,898.60
(
-1.26%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 117617

Monday, 04/11/2011 1:06:38 PM

Monday, April 11, 2011 1:06:38 PM

Post# of 257251
MRK inks branded-generics deal for emerging markets with India’s Sun Pharma:

http://finance.yahoo.com/news/Merck-Co-Inc-and-Sun-Pharma-bw-2289043827.html?x=0

Financial terms were not disclosed.

The Global Demographic Tailwind, which manifests itself via escalating sales of branded generics in emerging markets, has become the most important growth driver for the global pharmaceutical industry.

See #msg-61699995, #msg-59590951, #msg-48556414, and #msg-50473238 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now